LIDOCAÏNE KABI 20 mg/mL

DRUG3 trials

Sponsors

Centre Hospitalier Universitaire Grenoble Alpes, GCS Ramsay Sante Enseignement Et Recherche, Centre Hospitalier Universitaire De Nantes

Conditions

Major patients receiving morphine spinal anaesthesia for major gastrointestinal or abdominal surgery by scheduled laparotomy.emergency abdominal surgerysubarachnoid hemorrhage

Phase 2

Evaluation of the efficacy of sphenopalatine block in headache in patients with non-traumatic subarachnoid hemorrhage (SAH) after training of neurosurgical intensive care nurses.

RecruitingCTIS2024-514282-19-00

Centre Hospitalier Universitaire Grenoble Alpessubarachnoid hemorrhage

Start: 2025-05-30Target: 70Updated: 2024-11-26

Phase 3

A phase III, randomized, double-blind study assessing the efficacy and safety of intravenous lidocaine versus placebo in patients receiving intrathecal morphine analgesia in major digestive or abdominal surgery by laparotomy

Not yet recruitingCTIS2025-521206-18-00

GCS Ramsay Sante Enseignement Et RechercheMajor patients receiving morphine spinal anaesthesia for major gastrointestinal or abdominal surgery by scheduled laparotomy.

Target: 76Updated: 2025-06-27

Evaluation of the efficacy of intravenous lidocaine on chronic postoperative pain in patients requiring emergency abdominal surgery. Randomized, double-blind, controlled, multicenter study – LIDOC-POPEYE.

Not yet recruitingCTIS2025-523682-24-00

Centre Hospitalier Universitaire De Nantesemergency abdominal surgery

Target: 266Updated: 2026-08-17